Sharechat Logo

SFO gets top ASIC litigator as new boss

Wednesday 11th September 2013

Text too small?

The new head of the New Zealand Serious Fraud Office is an Australian, Julie Read, currently Special Counsel (Litigation) at the Australian Securities and Exchange Commission.

After a decade at ASIC, the Australian equivalent of the Financial Markets Authority, Read will move from her current base in Tasmania, where she has also been the ASIC state commissioner since 2002, to Auckland, where the 50-strong SFO is headquartered.

Read "is a senior public servant with significant experience at executive level managing work very similar to that of the SFO," the head of the State Services Commission Ian Rennie says in a statement.

"She has a track record of building and maintaining effective relationships with stakeholders and colleague agencies, while discharging her statutory role in complex and challenging investigations and prosecutions," he said.

The SFO and is responsible for detecting, investigating and prosecuting serious and complex financial crime, bribery and corruption. Read has been appointed for a term of three years and will take up her role on Oct. 21.

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors